• 1
    Gubler DJ, Clark GG. Dengue/Dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis 1995; 1: 5557.
  • 2
    Tassniyom S, Vasanawathana S, Chirawatkul A, Rojanasuphot S. Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. Pediatrics 1993; 92: 111115.
  • 3
    World Health Organization. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control, 2nd edn. Geneva: World Health Organisation 1997; 79.
  • 4
    Innis B. Antibody responses to dengue virus infection. In: Gubler, DJ, Kuno, G, eds. Dengue and Dengue Haemorrhagic Fever. New York: CAB International, 1997; 221243.
  • 5
    Vaughn DW, Green S, Kalayanarooj S et al. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis 1997; 176: 322330.
  • 6
    Reiskind MH, Baisley KJ, Calampa C, Sparp TW, Wats DM, Wilson ML. Epidemiological and ecological characteristics of past dengue virus infection in Santa Clara, Peru. Trop Med Int Health 2001; 6: 212218.
  • 7
    Fakeeh M, Zaki AM. Virologic and serologic surveillance for dengue fever in Jeddah, Saudi Arabia, 1994–99. Am J Trop Med Hyg 2001; 65: 764767.
  • 8
    Chungue E, Marchè G, Plichart R, Boutin JP, Roux J. Comparison of immunoglobulin G enzyme-linked immunosorbent assay (IgG-ELISA) and hemagglutination inhibition (HI) test for detection of dengue antibodies. Prevalence of dengue IgG-ELISA antibodies in Tahiti. Trans Roy Soc Trop Med Hyg 1989; 83: 708711.
  • 9
    Heyes CG, Phillipsa IA, Callahan JD et al. The epidemiology of dengue virus infection among urban, jungle, and rural populations in the Amazonas region of Peru. Am J Trop Med Hyg 1996; 55: 459463.
  • 10
    Desparis X, Roche C, Murgue E, Chungue E. Possible dengue sequential infection: dengue spread in a neighbourhood during the 1996/97 dengue-2 epidemic in French Polynesia. Tropmed Int Health 1998; 3: 866871.